Clarkston Consulting
Skip to content

Pharmaceutical Consulting

Clarkston’s pharmaceutical consultants help our clients develop and activate strategies to address their specific challenges and emerging trends to drive business.

Contact Our Pharmaceutical Consulting Team

Industry Challenges

Our pharmaceutical consulting team is prepared to help your company face some of today’s most pressing challenges.

Patient Engagement

Companies taking a patient-centered approach are better able to establish personalized connections for their patients and meaningfully engage with them throughout the entire treatment journey.

R&D and Innovation

An inherent challenge for businesses is: how do we fail faster? Investment in R&D, data, and analytics, and talent recruitment will contribute to overall industry innovation for treatment and prevention.


The pharmaceutical field is full of confidential data, from patient records to trial results to patented work; it is absolutely vital to protect this data and IP from any cybersecurity threat.

Supply Chain

Global supply chain disruption and API scarcity will force the industry to diversify sourcing locations and establish new supplier networks – all while providing real-time, full-product visibility and traceability.

Transition to Cell and Gene Therapy

The field of cell and gene therapy is evolving quickly and facing continued technological, regulatory, and commercialization hurdles.

Equitable Clinical Trials

Diversity and equity in clinical trial design as it relates to protocols, patient enrollment, retention, site selection, and readiness is essential to properly measure treatment efficacy of therapies for all communities and address existing health inequities.

Preparing for Commercial Launch?

Clarkston supports late-stage clinical companies on their path to commercialization. Leveraging deep industry expertise and recognized functional and business process leadership to help companies transition from development to commercialization, ensuring sustainable, long-term growth.

Clinical-Stage and Commercial Launch Services


A Rare Genetic Disease Biopharmaceutical Organization


Prototype to Launch: A Digital Tool to Facilitate Phase 3 Clinical Trials

More than 10,000 rare disease patients referred through the bespoke digital tool

Trained dozens of pharmaceutical executives and leaders on how to successfully and compliantly use the new digital tool to streamline workflows and key processes

Digital tool has been in place for >12 months and successfully used daily by a variety of stakeholders (HCPs, PIs, MSLs, clinical operations, others)

Download the Case Study

Contact Clarkston To Learn More About Our Pharmaceutical Consulting Practice

Contact Clarkston To Learn More About Our Pharmaceutical Consulting Practice

  • Clarkston Consulting requests your contact information so we may accurately and effectively respond to your request, as well as share our research and content with you. To learn more, please visit our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.